Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis

Journal of Renal Nutrition

Volumn 29, Issue 3, 2019, Pages 209-220

  McFarlane, Catherine ^a,b,c   Ramos, Christiane I ^a,d,e   Johnson, David W ^b,e,f   Campbell, Katrina L ^a,e  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Sunshine Coast University Hospital   (Australia)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ADULT; CHRONIC KIDNEY FAILURE; DIETARY SUPPLEMENT; DYSBIOSIS; FEMALE; HUMAN; INTESTINE FLORA; KIDNEY; MALE; MEDLINE; META ANALYSIS; MICROBIOLOGY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; DIETARY SUPPLEMENTS; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; KIDNEY; MALE; MEDLINE; PATIENT OUTCOME ASSESSMENT; PREBIOTICS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; SYNBIOTICS;

EID: 85055153018     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2018.08.008     Document Type: Article

References (41)

1. Bello, A.K., Levin, A., Tonelli, M., et al. Assessment of Global kidney health Care status. JAMA 317 (2017), 1864–1881.
2. Chadban, S.J., Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 14 (2003), 131S–138S.
3. Weiner, D.E., Chronic kidney disease as a risk factor for cardiovascular disease and all-Cause mortality: a pooled analysis of Community-Based studies. J Am Soc Nephrol 15 (2004), 1307–1315.
4. Stenvinkel, P., Carrero, J.J., Axelsson, J., Lindholm, B., Heimburger, O., Massy, Z., Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol 3 (2008), 505–521.
5. Moradi, H., Sica, D.A., Kalantar-Zadeh, K., Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol 38 (2013), 136–148.
6. Vaziri, N.D., Wong, J., Pahl, M., et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 83 (2013), 308–315.
7. Poesen, R., Evenepoel, P., de Loor, H., et al. The influence of prebiotic Arabinoxylan Oligosaccharides on microbiota derived uremic Retention solutes in patients with chronic kidney disease: a randomized controlled trial. PLoS One, 11, 2016, e0153893.
8. Sirich, T.L., Plummer, N.S., Gardner, C.D., Hostetter, T.H., Meyer, T.W., Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 9 (2014), 1603–1610.
9. Rossi, M., Johnson, D.W., Morrison, M., et al. Synbiotics Easing renal failure by improving gut Microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol 11 (2016), 223–231.
10. Meijers, B.K., De Preter, V., Verbeke, K., Vanrenterghem, Y., Evenepoel, P., p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25 (2010), 219–224.
11. Salmean, Y.A., Segal, M.S., Palii, S.P., Dahl, W.J., Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients. J Ren Nutr 25 (2015), 316–320.
12. Taki, K., Takayama, F., Niwa, T., Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J Ren Nutr 15 (2005), 77–80.
13. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical Practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3 (2013), 1–150.
15. Wishart, D.S., Tzur, D., Knox, C., et al. HMDB: the human Metabolome Database. Nucleic Acids Res 35 (2007), D521–D526.
16. Higgins, J.P.T., Green, S., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011 Available at: http://handbook.cochrane.org Accessed June 2018.
17. Schünemann, H.B.J., Guyatt, G., Oxman, A., (eds.) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations, 2013 Available at: guidelinedevelopment.org/handbook Accessed June 2018.
18. Bliss, D.Z., Stein, T.P., Schleifer, C.R., Settle, R.G., Supplementation with gum Arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am J Clin Nutr 63 (1996), 392–398.
19. Dehghani, H.H.F., Mozaffari-Khosravi, H., Nouri-Majelan, N., Dehghani, A., Synbiotic supplementations for Azotemia in patients with chronic kidney disease: a randomized controlled trial. Iran J Kidney Dis 10 (2016), 351–357.
20. Guida, B., Germanò, R., Trio, R., et al. Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial. Nutr Metab Cardiovasc Dis 24 (2014), 1043–1049.
21. Ranganathan, N., Friedman, E.A., Tam, P., Rao, V., Ranganathan, P., Dheer, R., Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 25 (2009), 1919–1930.
22. Ranganathan, N.R.P., Friedman, E.A., Joseph, A., et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27 (2010), 634–647.
23. Younes, H., Egret, N., Hadj-Abdelkader, M., et al. Fermentable carbohydrate supplementation alters nitrogen excretion in chronic renal failure. J Ren Nutr 16 (2006), 67–74.
24. Borges, N.A., Carmo, F.L., Stockler-Pinto, M.B., et al. Probiotic supplementation in chronic kidney disease: a double-blind, randomized, placebo-controlled trial. J Ren Nutr 28 (2017), 28–36.
25. Cruz-Mora, J., Martinez-Hernandez, N.E., Martin del Campo-Lopez, F., et al. Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease. J Ren Nutr 24 (2014), 330–335.
26. Natarajan, R., Pechenyak, B., Vyas, U., et al. Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients. Biomed Res Int, 2014, 2014, 568571.
27. Soleimani, A., Zarrati Mojarrad, M., Bahmani, F., et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int 91 (2016), 435–442.
28. Viramontes-Horner, D., Marquez-Sandoval, F., Martin-del-Campo, F., et al. Effect of a symbiotic gel (Lactobacillus acidophilus + Bifidobacterium lactis + inulin) on presence and severity of gastrointestinal symptoms in hemodialysis patients. J Ren Nutr 25 (2015), 284–291.
29. Xie, L.M., Ge, Y.Y., Huang, X., Zhang, Y.Q., Li, J.X., Effects of fermentable dietary fiber supplementation on oxidative and inflammatory status in hemodialysis patients. Int J Clin Exp Med 8 (2015), 1363–1369.
30. Wang, I.K., Wu, Y.Y., Yang, Y.F., et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes 6 (2015), 423–430.
31. Chiavaroli, L., Mirrahimi, A., Sievenpiper, J.L., Jenkins, D.J., Darling, P.B., Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 69 (2015), 761–768.
32. Vaziri, N.D., Yuan, J., Norris, K., Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol 37 (2013), 1–6.
33. Vaziri, N.D., Goshtasbi, N., Yuan, J., et al. Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am J Nephrol 36 (2012), 438–443.
34. Zoetendal, E.G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A.D.L., de Vos, W.M., Mucosa-associated bacteria in the human gastrointestinal Tract are Uniformly Distributed along the colon and differ from the Community Recovered from Feces. Appl Environ Microbiol 68 (2002), 3401–3407.
35. Vaziri, N.D., Effect of synbiotic therapy on gut–derived uremic toxins and the intestinal microbiome in patients with CKD. Clin J Am Soc Nephrol 11 (2016), 199–201.
36. Rossi, M., Klein, K., Johnson, D.W., Campbell, K.L., Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int J Nephrol, 2012, 2012, 673631.
37. Singh, S., Stroud, A.M., Holubar, S.D., Sandborn, W.J., Pardi, D.S., Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev, 2015, CD001176.
38. Backhed, F., Fraser, C.M., Ringel, Y., et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12 (2012), 611–622.
39. Haller, D., Antoine, J.M., Bengmark, S., Enck, P., Rijkers, G.T., Lenoir-Wijnkoop, I., Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 140 (2010), 690S–697S.
40. Rossi, M., Johnson, D.W., Xu, H., et al. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 25 (2015), 860–865.
41. Kalantar-Zadeh, K., Kopple, J.D., Deepak, S., Block, D., Block, G., Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12 (2002), 17–31.